Sinphar Pharmaceutical Co., Ltd.
1734.TW- 1D
- -3.0%
Sinphar Pharmaceutical Co., Ltd. in brief
Sinphar Pharmaceutical Co., Ltd. is a listed company in the Biotechnology industry, based in Taiwan. Its market value was $170 M on 20 November 2026, which makes it the 16,808th largest listed company in the world and the 799th largest in Taiwan on this site. Its shares trade under the symbol 1734.TW (Taiwan).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Sinphar Pharmaceutical Co., Ltd. timeline
- 2002
- 📈Listed on Taiwan Stock Exchange as 1734First day of listing in the exchange's official list.
Events of Sinphar Pharmaceutical Co., Ltd. from the exchanges' official lists. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Sinphar Pharmaceutical Co., Ltd. share price · Taiwan (1734.TW)
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Nov 20, 2026 | 28.10 | 28.55 | 27.70 | 27.75 | -3.0% | 480,409 |
| Nov 19, 2026 | 29.05 | 29.20 | 28.60 | 28.60 | -1.7% | 264,398 |
| Nov 18, 2026 | 29.30 | 29.30 | 29.05 | 29.10 | -0.3% | 134,092 |
| Nov 17, 2026 | 29.50 | 29.85 | 29.15 | 29.20 | -1.5% | 293,815 |
| Nov 16, 2026 | 30.00 | 30.00 | 29.65 | 29.65 | -1.3% | 174,389 |
| Nov 13, 2026 | 30.00 | 30.25 | 30.00 | 30.05 | +0.2% | 129,820 |
| Nov 12, 2026 | 29.95 | 30.15 | 29.95 | 30.00 | -0.5% | 140,703 |
| Nov 11, 2026 | 29.90 | 30.15 | 29.90 | 30.15 | +0.2% | 147,325 |
| Nov 10, 2026 | 30.05 | 30.15 | 29.90 | 30.10 | -0.2% | 216,145 |
| Nov 9, 2026 | 30.00 | 30.20 | 29.90 | 30.15 | +0.8% | 303,091 |
| Nov 6, 2026 | 29.60 | 30.20 | 29.35 | 29.90 | -1.2% | 573,467 |
| Nov 5, 2026 | 30.40 | 30.60 | 30.20 | 30.25 | -0.7% | 199,862 |
| Nov 4, 2026 | 30.40 | 30.65 | 30.20 | 30.45 | +0.2% | 243,534 |
| Nov 3, 2026 | 30.80 | 30.80 | 30.30 | 30.40 | -0.7% | 235,609 |
| Nov 2, 2026 | 30.75 | 30.75 | 30.45 | 30.60 | +0.2% | 79,451 |
| Oct 30, 2026 | 30.75 | 30.95 | 30.50 | 30.55 | -0.7% | 302,322 |
| Oct 29, 2026 | 30.75 | 30.85 | 30.55 | 30.75 | +0.2% | 228,927 |
| Oct 28, 2026 | 30.85 | 30.85 | 30.65 | 30.70 | 0.0% | 144,859 |
| Oct 27, 2026 | 31.00 | 31.00 | 30.65 | 30.70 | 0.0% | 104,190 |
| Oct 22, 2026 | 30.75 | 30.90 | 30.70 | 30.70 | 0.0% | 143,365 |
| Oct 21, 2026 | 30.85 | 30.95 | 30.70 | 30.70 | -0.3% | 105,110 |
| Oct 20, 2026 | 30.85 | 30.95 | 30.60 | 30.80 | -0.2% | 90,237 |
| Oct 19, 2026 | 31.25 | 31.25 | 30.80 | 30.85 | -1.3% | 188,187 |
| Oct 16, 2026 | 31.60 | 31.60 | 31.25 | 31.25 | -1.1% | 137,835 |
| Oct 15, 2026 | 31.80 | 31.80 | 31.40 | 31.60 | -0.3% | 219,686 |
| Oct 14, 2026 | 31.75 | 31.80 | 31.50 | 31.70 | +0.3% | 80,426 |
| Oct 13, 2026 | 31.60 | 31.75 | 31.30 | 31.60 | -0.5% | 214,318 |
| Oct 12, 2026 | 32.40 | 32.55 | 31.50 | 31.75 | -2.0% | 238,609 |
| Oct 8, 2026 | 32.10 | 32.65 | 32.00 | 32.40 | +0.9% | 216,846 |
| Oct 7, 2026 | 32.10 | 32.15 | 31.85 | 32.10 | — | 118,663 |
Prices in TWD from the Taiwan Stock Exchange; the last 30 trading days are listed, the chart shows up to ten years. For information only; not investment advice.
Sinphar Pharmaceutical Co., Ltd. share price statistics
Changes compare closing prices; volatility is the annualised standard deviation of daily returns. Prices are as published by the exchange, not adjusted for splits, bonus issues or dividends. For information only; not investment advice.
Market cap history
World rank over time
Rank in Taiwan: #901 (Jan 2020) · #675 (Jan 2021) · #879 (Jan 2022) · #730 (Dec 2022) · #870 (Jul 2023) · #856 (Jan 2024) · #845 (Nov 2026) · #852 (Nov 2026) · #841 (Nov 2026) · #840 (Nov 2026) · #839 (Nov 2026) · #819 (Nov 2026) · #799 (Nov 2026)
Mutual funds holding Sinphar Pharmaceutical Co., Ltd.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 State Street SPDR Portfolio Emerging Markets ETFSSGA Funds Management, Inc. | 3.18 M | $3 M | — | 0.02% | no change | Jun 30, 2026 |
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 935,446 | $1 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 455,462 | $0 M | — | <0.01% | +15% | Jul 31, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 335,457 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Core Equity 2 ETFDimensional Fund Advisors LP | 201,582 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 125,714 | $0 M | — | 0.02% | −25% | Jun 30, 2026 |
| 🇺🇸 Dimensional World ex. U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 121,914 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Core Equity Market ETFDimensional Fund Advisors LP | 90,153 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value ETFDimensional Fund Advisors LP | 59,875 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Targeted Value PortfolioDimensional Fund Advisors LP | 52,168 | $0 M | — | <0.01% | +92% | Jul 31, 2026 |
| 🇺🇸 World ex U.S. Core Equity PortfolioDimensional Fund Advisors LP | 50,249 | $0 M | — | <0.01% | +46% | Jul 31, 2026 |
| 🇺🇸 Emerging Markets ex China Core Equity PortfolioDimensional Fund Advisors LP | 47,666 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Strategic Advisers Emerging Markets FundStrategic Advisers LLC | 40,000 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP | 36,902 | $0 M | — | 0.01% | +55% | Jul 31, 2026 |
| 🇺🇸 Emerging Markets Sustainability Core 1 PortfolioDimensional Fund Advisors LP | 27,646 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Sustainability Core 1 ETFDimensional Fund Advisors LP | 11,130 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 3,402 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis Responsible Emerging Markets Equity ETFAmerican Century ETF Trust | 1,134 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets ex China Core Equity ETFDimensional Fund Advisors LP | 1,113 | $0 M | — | <0.01% | +6.0% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 19 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
How Sinphar Pharmaceutical Co., Ltd. compares in Biotechnology
- Market cap$170 M · higher than 42% of 726
- 🇺🇸 AN2 Therapeutics, Inc.$172 M
- 🇺🇸 Minerva Neurosciences, Inc.$167 M
- 🇺🇸 PepGen Inc.$175 M
- 🇺🇸 Acumen Pharmaceuticals, Inc.$166 M
- 🇺🇸 Cue Biopharma, Inc.$177 M
- 🇺🇸 Invivyd, Inc.$177 M
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Sinphar Pharmaceutical Co., Ltd.🇹🇼 | $170 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Regenxbio Inc.$513 M
- Pharmicell Co., Ltd.$514 M
- Oneness Biotech Co., Ltd.$520 M
- Pulike Biological Engineering, Inc.$524 M
- Contineum Therapeutics, Inc.$534 M
- Entera Bio Ltd.$543 M
Sources and freshness
- Market cap:
- Nov 20, 2026
- Profile updated:
- Nov 21, 2026
Figures from Market data, value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Sinphar Pharmaceutical Co., Ltd.? Verify and update this profile — free
Show Sinphar Pharmaceutical Co., Ltd.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.